HEPARIN, A MAMMALIAN
glycosaminoglycan (GAG),2 has the highest negative charge density of any known biological macromolecule.
It thus is prone to ionic interaction with a variety of proteins such as enzymes, enzyme inhibitors, extracellular-matrix proteins, various cytokines, and others (1) . Such interaction is exploited in the purification of "heparin-binding proteins," which are adsorbed to immobilized heparin at low ionic strength and subsequently eluted with salt. The appreciable purification often achieved suggests an element of selectivity beyond that expected for simple cation-exchange chromatography.
Heparin is isolated on a commercial basis from animal tissues (pig intestinal mucosa; bovine lung) and is used in the clinic as an antithrombotic drug. In the intact tissue it is confined to mast cells, where it is stored in cytoplasmic granules. Heparan sulfate (HS), on the other hand, has ubiquitous distribution on cell surfaces and in the extracellular matrix. It is generally less sulfated than heparin and has a more varied structure. Interactions between HS and specified proteins are being increasingly implicatedin a varietyof physiological processes,such as cell adhesion, enzyme regulation, cytokine action, etc. (1) .
Heparin and HS are both synthesized as proteoglycans (PGs), which consist of GAG chains covalently bound to a protein core. A single protein, serglycin, has been identified as the protein constituent of heparin PGs, whereas a variety of proteins provide core structures of HS PGs 
sequences
[where L-iduronic acid (IdoA) is the C5-epimerization product of G1cA] (Fig. 1B) . This process, which generates the most abundant disaccharide unit in heparin, will be referred as heparin "default modification."
Heparin, and in particular, HS, contain structures that deviate from the product of default modification. Such structures arise through "modulated modification," which may differ from the default process in either of two ways. The pathway may be incomplete, due to lack of all ( 
POLYSACCIIARIDE-PROTEIN INTERACTIONS
Binding of heparin/HS sequences to proteinsis generally (although not exclusively) ionic, and thus involves positively charged, usually clustered, amino acid residues in the protein components.
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GlcNH3, Conceivably, however, they may also be differentially expressed in separate GAG chains of the HS type (Fig. 3) . (13) . These findings suggest an organ-specific and age-related control of G1cA 2-0-sulfation.
Even though the precise functional role of the sulfated GlcA residue is unknown, previous studies of cultured hepatocytes revealed a nuclear pool of HS with a strikingly high content of the -GlcA(2-0S03)-G1cNSO3(6-0S03)-disaccharide unit (14) . Nuclear HS was tentatively implicated with the control of cell proliferation. Heparin
[which also contains small amounts of GlcA(2-0S03) units (2) 
Multiple interaction sites
HS modulates the biological activity of interferon-? by interacting with the dimeric cytokine. Interferon binding HS fragments, encompassing as many as 40-50 monosaccharide units, were shown to consist of two terminal sulfated domains, each binding to one interferon-y monomer, separated by a nonsulfated G1cA-rich sequence (18) . This finding points to an important general concept: properly spaced sequences of the appropriate structurealong a GAG chain may form functional domains that act in a concerted manner (Fig.28 ). Such domains may bind to identical peptide sites, as in the case of interferon-y, or to different sites, as in the heparmn-antithrombin-thrombin interaction (8 direct binding of heparin to the receptor itself (22) ; indeed, FGF receptor 4 can be activated by heparin, even in the absence of growth factor (23) . The effects of selectively 0-desulfated heparin preparations in FGF-2-dependent cell proliferation assays suggested that both IdoA 2-0-and GlcN 6-0-sulfate groups were needed for activity (20) , contrary to growth factor binding alone, which required 2-0-sulfate groups only (see above). These and other (24) findings were interpreted in terms of a ternary complex, with FGF-2 and its receptor binding to adjacent, distinct sites on the same polysaccharide chain. This model predicts that whereas a GAG chain that contains the appropriately spaced growth factor binding and receptor binding sequences will promote the FGF-induced cellular response, other species with only one of the sequences, or with incorrectly spaced binding regions, will inhibit the response.
Domain spacing, in turn, is determined by the length of any intervening sequence and further influenced by the conformational flexibility of such sequences.
Finally, we consider the possibility of different functional GAG domains residing in different HS chains that are bound to the same core protein (Fig. 2C) . PGs differ from each other both in the number of potential HS attachment sites and the location of such sites along the protein backbone (2, 3) . In glypican, for example, the HS attachment sites appear to be predominantly located close to each other, between the membrane-bound domain and a large extracellular globular domain, whereas syndecans 1 and 3 have more extended core proteins that may carry HS both at the proximal and distal ends of their extracellular domains.
The latter arrangement could conceivably facilitate the differential interaction of separate HS chains with several proteins concomitantly.
Indeed, syndecan-1, immobilized by interacting through one of its HS chains with fibronectin or collagen, retains its ability
POLYSACCHARIDE BIOSYNTHESIS
The
Polysaccharide chain initiation
The enzymes responsible for GAG biosynthesis are located largely in the Golgi apparatus.
A and it is currently believed that, in the intact cell, this and other modification reactions (see below) occur while the chain is still being elongated (30) (FIg. 4C and FIg. 5) . (Fig. 4) . Deviations from this pathway may be due to either restricted or further extended modification. Reactions of the latter category, which generally involve only minor portions of the polysaccharide chains, include 0-sulfation at C2 of G1cA (31) and at C3 of G1cN units The most conspicuous restriction of polymer modification is due to incomplete N-deacetylation/N-sulfation. Because the enzymes that catalyze the C5-epimerization and various 0-sulfation reactions all require N-sulfate group. for substrate recognition (within a defined distance from the actual target site), sequences composed of consecutive N-acetylated disaccharide units will be devoid of IdoA and 0-sulfate residues (1, 6). Such sequences (blue in Fig. 4 ) are typical for HS but are rare in heparin chains (1) . Given the constraints of the modification process dictated by substrate specificity and access to a survey of authentic identified structures, a scheme of "permitted"
and "forbidden" sequences has been compiled that presumably applies to the entire heparin/HS family ( Fig. 2 in ref 1 ). This scheme does not include the N-unsubstituted G1cN unit, which has yet to be placed in a structural context (see legend to Fig. 4 ).
Regulation of polymer modification: implications of a model
The scheme in Fig. 4 illustrates the assumed order of the various modification reactions, as deduced essentially from the substrate specificities of the corresponding enzymes. However, the mode of selection of target residues extends beyond a simple matter of substrate specificity. We have no clue as to what mechanism determines whether a particular region of a precursor polysaccharide is going to be N-deacetylated/N-suifated, and thus subject to further modification, or remain N-acetylated and unmodified. Even within the N-sulfated regions (red in Fig.  4) , potential target units often escape modification. For example, a G1cA unit located between two N-sulfated G1cN residues may undergo C5-epimerization to IdoA, but may also remain unchanged.
Similarly, 6-0-sulfation of a G1cNSO3 unit located between two IdoA(2-0S03) residues is optional. Due to such selectivity, the structural complexity and heterogeneity of the polysaccharide chain will increase through the modification process. The functional relevance of the selection mechanism is apparent, as it provides the basis for the generation of protein binding regions of defined structure.
Our current model depicting the physical course of heparin/HS formation (Fig. 5) features simultaneous elongation and modification of the polysaccharide precursor, in accord with the postulated coupling between the polymerization and N-deacetylation/N-sulfation reactions (30) . A glycosyltransferase/N-deacetylase/N-sulfotransferase complex, located at the nonreducing end of the chain, will generate saccharide sequences with N-sulfate or residual N-acetyl groups, which are then subjected to further downstream modification by enzymes that act in a processive fashion along the polysaccharide chain. Given the main features of this model, we may consider the generation of some structural domains identified in heparinlHS chains. A process in which every disaccharide unit formed would be attacked by each enzyme indicated in Fig. 5 (except the 3-0-sulfotransferase) would lead to a uniform product with the structure expected from default modification (Fig. 1B) . Deviations from this course involving restricted modification, the hallmark of HS biosynthesis, would require an interrupted, on-off The FASEBJournal SALMIVIRTA ETAL mode of processiveenzyme action.The versatility of this modulation is intriguing. How can we visualize the generation, through the action of a common assembly line, of a polysaccharide chain that contains extended N-acetylated as well as N-sulfated regions of varying length, but also sequences of alternating N-acetylated and N-sulfated disaccharide units that may account for as much as 30%
of the total mass of a HS chain (6) . By what mechanism (or mechanisms) are certain disaccharide units within a contiguous N-sulfated block sequence selected to escape the processive (?) action of one or more of the three major "downstream" enzymes, i.e., the G1cA C5-epimerase, the IdoA 2-O-sulfotransferase, and the GlcN 6-0-sulfotransferase?
What causes the apparent separation of Figure   5 . A model of the biosynthetic assembly of heparin/HS in the Golgi complex. A nascent polysaccharide chain, thereducing end boundto a protein core, isshowntotraverse thecomponents ofthebiosynthetic enzymemachinery. The building blocks ofthechain, i.e., sugar nucleotides and PAPS. aretransported across theGolgi membrane fromthecytoplasm wheretheir formation is fueled by cellular ATP. The "polymerase"
(GlcNAc/GlcA transferase) adds alternating GlcNAc and GIcA units to the elongating polymer, which is concomitantly, yet sequentially, modified by enzymes catylyzing N-deacetylation and N-sulfation of GIcNAc units, C5-epimerization of G1cA to IdoA units, and 0-sulfation at various positions. Enzymes (the "polymerase" and the GIcNAc N-deacetylase/N-sulfotransferase) so far shown to catalyze more than one reaction are indicated. The remaining enzymes have been arbitrarily combined into complexes; indeed, the organization of all enzymes into one major complex appears entirely plausible. The mode of interaction of such a complex with the polysaccharide chain, resulting in the generation of alternating modified (red in Fig. 4 ) and unmodified (blue in Fig. 4) target sites for 2-0-sulfation, essentially restricted to Nsulfated blocks, and 6-0-sulfation, which occurs within as well as outside these blocks (32; 32a Fig. 4; see ref 1 ). The mechanism behind the selection of certain GlcA units for 2-0-sulfation is unknown.
Proteins involved in the biosynthetic process
The proteins required to form a heparin or a HS PG include the appropriate core protein, enzymes that catalyze the formation and modification of GAG chains, and any auxiliary proteins that may be involved in the process.
Core proteins
The various core proteins known to carry heparin (serglycm) or HS (syndecans, perlecan, glypicans, and others) GAG chains have been discussed in previous reviews (1, 3, 4, 35, 36) . (26) . None of the enzymes involved in forming the linkage region tetrasaccharde sequence has yet been purified and cloned. A CHO cell mutant unable to produce HS was found to be defective with regard to both the GlcAtransferaseand the GIcNAc-transferase reactions (37) . Because the defect was presumably due to a single mutation, it was tentatively concluded that the two transferase reactions were catalyzed by a single enzyme protein. This assumption was supported by the identification of a -70 kDa proteinin bovine serum that promoted both reactions (38) . The enzyme-deficient CHO cell line accumulated a protein-bound pentasaccharide composed of an aGlcNAc unit bound to the linkage region tetrasaccharide (39) , in accord with the notion that the "polymerase" differs from the G1cNAc-transferase that adds the first G1cNAc unit of the chain (28) .
The notion of two distinct reactions being catalyzed by a single enzyme implies a rational means of promoting alternating events along a polymer chain. In fact, a similar arrangement applies to the two first polymer modification reactions, N-deacetylation and N-sulfation of G1cNAc units, which are both associated with the same -110 kDa enzyme (refs [40] [41] [42] and references therein). The regulation of these reactions is essential, because the resultant distribution of N-acetyl and N-sulfate groups will control the followi-g modification reactions, and in fact will determine whether the final product will be classified a heparin or a HS. The N-deacetylase/N-sulfotransferase occurs in two distinct forms with partly different catalytic properties.
One of these forms, first isolated from mouse mastocytoma (40) ,was associatedwith the biosynthesis of heparin, whereas the other, derived from rat liver (41) Differential roles for these enzymes in regulating the N-deacetylation/N-sulfation process during heparin/HS biosynthesis were suggested by the finding that transfection of a HS-producing cell line with cDNA endocing the mast-cell N-deacetylase/N-sulfotransferase induced a drastic change of the N-substituent pattern of the HS produced by the cell toward that typical for heparim (43) .
A -52 kDa GlcA C5-epimerase has been purified to homogeneity from bovine liver (44) . This enzyme cata-
The FASEBJournal SALMIVIRTA Ef AL lyzes the reversible conversion of GLcA to IdoA units, equilibrium favoring retention of the D-gluco configuration. However, whereas information on the kinetics of solubilized enzyme preparations may apply in part also to the intact biosynthetic system, the experimental conditions deviate drastically from those pertaining to GAG formation in the living cell. In this process, chain elongation and modification is completed within a few minutes or less, and individual reactions such as the G1cA CSepimerization would not be allowed to approach equilibrium (45) . In fact, studies of the formation of heparin in a mastocytoma microsomal fraction failed to show any "back-epimerization"
(from IdoA to G1cA); the intact biosynthetic system is capable of delivering heparin chains in which 80% of the total hexuronic acid is IdoA. This remarkable efficiency is obviously, albeit still mysteriously, due to the mode of concerted interaction of the membrane-bound biosynthetic enzymes with their polymeric substrate.
Information regarding the molecular characteristics of the various 0-sulfotransferases is still scanty. A -60 kDa proteinfraction, derived from detergent-solubilized mouse mastocytoma tissue, was found to catalyze both IdoA 2-0-and GleN 6-0-sulfation, suggesting that these two reactions might also be associated with the same enzyme (46) . On the other hand, cultured
Chinese hamster ovary cells were found to release a GlcN 6-0-sulfotransferase into the medium while IdoA 2-O-sulfotransferase was retained by the cells (47) . Purification of the former enzyme yielded two, 52 and 45 kDa, protein fractions.
It cannot be concluded at present whether these discrepancies reflect actual differences between 0-sulfotransferases that catalyze the corresponding reactions in heparin and HS biosynthesis or proteolytic processing of a common, membrane-bound O-sulfotransferase.
Auxiliary proteins
Scattered observations point indirectly to the involvement of additional auxiliary proteins in the biosynthetic process. The mouse mastocytomal N-deacetylase/N-sulfotransferase thus requires a polycationic cofactor for activity (40) , whereas the corresponding rat liver enzyme does not (48) . The endogenous polycation in the mast cell, apparently a polypeptide, may be replaced by synthetic polymers in assays of the purified enzyme. Moreover, analysis of cell mutants deficient in production of HS with high affinity for antithrombin implicated a regulatory component believed to somehow coordinate the action of the biosynthetic enzymes involved in generating the specific antithrombin-binding pentasaccharide sequence (49) . Undoubtedly there are other, still undetected, proteins with similar regulatory functions. Such proteins need to be isolated, cloned, and characterized along with the biosynthetic enzymes in order to gain a better understanding of PG biosynthesis and its regulation. We may ultimately visualize the generation of artificial biosynthetic machineries, based on recombinant proteins assembled in appropriate membrane systems, that will enable the efficient formation of saccharide chains with specifically tailored structure.
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